Accreditation bodies assess pharmaceutical manufacturing safety on documented evidence of consistent practice. Cost pressure and quality expectations on this part of health and pharmaceutical services are rising at the same time. The difficulty is not agreeing that the health and pharmaceutical services discipline matters — it is deciding what to stop doing to make room for it. Participants develop a defensible line of reasoning for the choices they make about pharmaceutical manufacturing safety. The course gives participants a defensible structure for the health and pharmaceutical services capability and the judgement to adapt it. Every module pairs a short input on the practice within health and pharmaceutical services with structured practice on the participant's own material. Participants who influence pharmaceutical manufacturing safety without directly controlling it will find the content directly usable. Post-incident reviews keep identifying weaknesses in this aspect of health and pharmaceutical services that were visible long before the incident. Participants finish with a short, specific brief on the practice within health and pharmaceutical services ready to put in front of a decision maker.
Expected Learning Outcomes
✓
Assess and control infection risk associated with pharmaceutical manufacturing safety.
✓
Design a process for pharmaceutical manufacturing safety that clinical staff can follow without obstructing care.
✓
Select indicators that show whether pharmaceutical manufacturing safety is improving, and reject those that only look useful.
✓
Build a register of the risks attaching to pharmaceutical manufacturing safety and keep it current.
✓
Agree the first three actions on pharmaceutical manufacturing safety that will be taken on returning to work.
✓
Manage the supply chain and cold chain supporting pharmaceutical manufacturing safety.
✓
Design medication and treatment safety controls within pharmaceutical manufacturing safety.
